AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma
Drug Resistance Updates · 2027-01 · 90 · 101508
DOI: 10.1016/j.drup.2026.101508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2027-01. Verfasst von Xiaoqing Guan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China. Electronic address: gu…. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China. Electronic address: guanxq@zjcc.org.cn.
- Center for Innovative Drug Research, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310018, China; College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou,…
- MOE Frontier Science Centre for Precision Oncology, University of Macau, 999078, Macao Special Administrative Region of China.
- Key Laboratory of Precision Medicine for Medical-Industrial Integration, Department of Oncology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei 063000, China.
- Key Laboratory of Precision Medicine for Medical-Industrial Integration, Department of Oncology, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei 063000, China. Electronic address: g…
- School of Preclinical Medicine, Chengdu University, Chengdu 610106, China. Electronic address: zhanglele@cdu.edu.cn.
Förderung
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Guan, X., Yang, W., Yao, Z., Cao, F., Liu, J., Miao, K., Mao, X., Sun, G., Zhang, L., & Qin, J. J. (2027). AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma. Drug Resistance Updates, 90, 101508. https://doi.org/10.1016/j.drup.2026.101508
Vancouver
Guan X, Yang W, Yao Z, Cao F, Liu J, Miao K, et al. AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma. Drug Resistance Updates. 2027;90:101508. doi:10.1016/j.drup.2026.101508
BibTeX
@article{Guan2027,
author = {Guan, Xiaoqing and Yang, Wenyan and Yao, Zhiyang and Cao, Fei and Liu, Jiaxuan and Miao, Kai and Mao, Xuanming and Sun, Guogui and Zhang, Lele and Qin, Jiang-Jiang},
title = {AKR1B1-dependent ferroptosis defense contributes to KRASG12C inhibitor resistance in pancreatic ductal adenocarcinoma},
journal = {Drug Resistance Updates},
year = {2027},
volume = {90},
pages = {101508},
doi = {10.1016/j.drup.2026.101508}
}
EUVIMED